Achieving a Major Molecular Response at the Time of a Complete Cytogenetic Response (CCgR) Predicts a Better Duration of CCgR in Imatinib-Treated Chronic Myeloid Leukemia Patients-Reference-Cited by-同舟云学术

Achieving a Major Molecular Response at the Time of a Complete Cytogenetic Response (CCgR) Predicts a Better Duration of CCgR in Imatinib-Treated Chronic Myeloid Leukemia Patients

Published:2006-05-15 Issue:10 Volume:12 Page:3037-3042
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Iacobucci Ilaria,Saglio Giuseppe,Rosti Gianantonio,Testoni Nicoletta,Pane Fabrizio,Amabile Marilina,Poerio Angela,Soverini Simona,Bassi Simona,Cilloni Daniela,Bassan Renato,Breccia Massimo,Lauria Francesco,Izzo Barbara,Merante Serena,Frassoni Francesco,Paolini Stefania,Montefusco Enrico,Baccarani Michele,Martinelli Giovanni

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate;JAMA Internal Medicine;2019-07-01

2. MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia;Haematologica;2019-03-28

3. FIRST LINE OF TREATMENT OF CHRONIC MYELOID LEUKEMIA IN CHILDREN AND ADOLESCENTS IN THE REPUBLIC OF BELARUS;Proceedings of the National Academy of Sciences of Belarus, Medical series;2018-09-16

4. Molecular Testing in Pediatric Oncology Practice;Molecular Pathology Library;2018

5. Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate;Clinical Lymphoma Myeloma and Leukemia;2017-02